Cargando…
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity
Background: Obesity is often associated with nonalcoholic fatty liver disease (NAFLD), which refers to a large spectrum of hepatic lesions including fatty liver, nonalcoholic steatohepatitis (NASH) and cirrhosis. Different investigations showed or suggested that obesity and NAFLD are able to increas...
Autores principales: | Massart, Julie, Begriche, Karima, Moreau, Caroline, Fromenty, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500243/ https://www.ncbi.nlm.nih.gov/pubmed/28691103 |
Ejemplares similares
-
Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
por: Begriche, Karima, et al.
Publicado: (2023) -
Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease
por: Massart, Julie, et al.
Publicado: (2022) -
Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver
por: Massart, Julie, et al.
Publicado: (2022) -
Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity
por: Allard, Julien, et al.
Publicado: (2020) -
Nonalcoholic Fatty Liver Disease Is a Risk Factor for Thiopurine Hepatotoxicity in Crohn’s Disease
por: George, Alvin T, et al.
Publicado: (2023)